(Q73026542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

P Annunziata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F Lore'

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Venturini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Morana

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Guarino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Borghi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G C Guazzi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

31 October 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

32-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

Autoimmunity in multiple sclerosis

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Antithyroid antibodies in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Frequency and significance of antinuclear antibodies in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Multiple sclerosis: immunological findings and possible implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

B-cell abnormalities in multiple sclerosis. A hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Antibodies to nuclear and smooth muscle antigens in multiple sclerosis and control patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

The effect of neonatal thyroidectomy on myelination in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Impairment of human brain development: glycoconjugate and lipid changes in congenital athyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

Influence of thyroid hormones on myelin proteins in the developing rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2899%2900168-9

10.1016/S0022-510X(99)00168-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10500271%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference